Benjamin Burnett
Stock Analyst at Stifel
(1.45)
# 3,105
Out of 4,818 analysts
71
Total ratings
38.78%
Success rate
-10.01%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Benjamin Burnett
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| FATE Fate Therapeutics | Maintains: Hold | $5 → $3 | $1.37 | +118.98% | 3 | Mar 6, 2025 | |
| CRSP CRISPR Therapeutics AG | Maintains: Hold | $53 → $49 | $39.26 | +24.81% | 6 | Feb 13, 2025 | |
| ACLX Arcellx | Maintains: Buy | $83 → $122 | $63.08 | +93.42% | 5 | Oct 18, 2024 | |
| BEAM Beam Therapeutics | Maintains: Buy | $66 → $69 | $19.13 | +260.69% | 2 | Sep 11, 2024 | |
| IDYA IDEAYA Biosciences | Maintains: Buy | $63 → $68 | $18.64 | +264.81% | 7 | Sep 10, 2024 | |
| ALLO Allogene Therapeutics | Maintains: Hold | $4.4 → $4.6 | $1.59 | +189.31% | 5 | May 14, 2024 | |
| ATRA Atara Biotherapeutics | Maintains: Hold | $120 → $58 | $6.80 | +745.59% | 4 | Apr 1, 2024 | |
| DTIL Precision BioSciences | Maintains: Buy | $690 → $780 | $5.37 | +14,425.14% | 2 | Sep 10, 2021 | |
| BLUE bluebird bio | Upgrades: Buy | $1,880 → $1,400 | $4.37 | +31,936.61% | 3 | Mar 27, 2020 | |
| RVMD Revolution Medicines | Maintains: Buy | $78 → $64 | $36.86 | +73.63% | 5 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $90 → $94 | $44.04 | +113.44% | 7 | Jan 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $4 | $1.38 | +189.86% | 5 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $10 | $1.53 | +553.59% | 3 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $3.21 | +678.82% | 11 | Sep 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $22 → $24 | $0.66 | +3,519.91% | 2 | Jun 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $16 | $0.78 | +1,961.06% | 1 | Jan 6, 2021 |
Fate Therapeutics
Mar 6, 2025
Maintains: Hold
Price Target: $5 → $3
Current: $1.37
Upside: +118.98%
CRISPR Therapeutics AG
Feb 13, 2025
Maintains: Hold
Price Target: $53 → $49
Current: $39.26
Upside: +24.81%
Arcellx
Oct 18, 2024
Maintains: Buy
Price Target: $83 → $122
Current: $63.08
Upside: +93.42%
Beam Therapeutics
Sep 11, 2024
Maintains: Buy
Price Target: $66 → $69
Current: $19.13
Upside: +260.69%
IDEAYA Biosciences
Sep 10, 2024
Maintains: Buy
Price Target: $63 → $68
Current: $18.64
Upside: +264.81%
Allogene Therapeutics
May 14, 2024
Maintains: Hold
Price Target: $4.4 → $4.6
Current: $1.59
Upside: +189.31%
Atara Biotherapeutics
Apr 1, 2024
Maintains: Hold
Price Target: $120 → $58
Current: $6.80
Upside: +745.59%
Precision BioSciences
Sep 10, 2021
Maintains: Buy
Price Target: $690 → $780
Current: $5.37
Upside: +14,425.14%
bluebird bio
Mar 27, 2020
Upgrades: Buy
Price Target: $1,880 → $1,400
Current: $4.37
Upside: +31,936.61%
Revolution Medicines
Apr 1, 2025
Maintains: Buy
Price Target: $78 → $64
Current: $36.86
Upside: +73.63%
Jan 24, 2025
Maintains: Buy
Price Target: $90 → $94
Current: $44.04
Upside: +113.44%
Dec 13, 2024
Maintains: Buy
Price Target: $9 → $4
Current: $1.38
Upside: +189.86%
Jun 3, 2024
Maintains: Buy
Price Target: $7 → $10
Current: $1.53
Upside: +553.59%
Sep 15, 2023
Reiterates: Buy
Price Target: $25
Current: $3.21
Upside: +678.82%
Jun 28, 2021
Upgrades: Buy
Price Target: $22 → $24
Current: $0.66
Upside: +3,519.91%
Jan 6, 2021
Initiates: Hold
Price Target: $16
Current: $0.78
Upside: +1,961.06%